Advancing diagnostics reagent development for emerging and rare diseases
As emerging pathogens and rare diseases continue to test global health systems, innovative diagnostic reagents are transforming how we detect, differentiate, and respond to complex conditions. A recent example of this is the ongoing mpox outbreak, which has highlighted specific gaps in testing methods and underscored the need for diagnostics to rapidly adapt to evolving pathogens. Whether it’s a resurgent poxvirus or an ultra-rare genetic disorder, innovative diagnostic reagents are essential tools in safeguarding global health.
